使用全国范围的全基因组测序量性病的变体贡献量化
Omid Sadeghi-Alavijeh1, Melanie My Chan1, Gabriel T Doctor1
1Centre for Kidney and Bladder Health, University College London, London, United Kingdom.
The Journal of clinical investigation
|August 27, 2024
概括
这项研究使用全基因组测序来量化囊性病 (CyKD) 的遗传风险. 研究结果揭示了多种不同的遗传贡献,为受CKD影响的家庭提供未来遗传测试和咨询信息.
科学领域:
- 遗传学 是一个遗传学.
- 基因组学就是基因组学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 囊性病 (CyKD) 主要是家族性,传统的基因发现方法容易产生偏见.
- 了解CKD的遗传结构对于准确的诊断和家庭咨询至关重要.
研究的目的:
- 对全基因组测序数据进行无假设分析,以量化CKD的遗传风险.
- 识别和评估各种遗传变异 (罕见和常见) 对CKD风险的贡献.
- 提供对CyKD的遗传贡献者的公正风险估计.
主要方法:
- 利用了来自100,000个基因组项目的1,209个CyKD病例和26,096个对照的全基因组测序数据.
- 采用无假设方法来估计个体基因和变异类型的疾病风险.
- 使用英国生物银行研究数据重复发现.
主要成果:
- 在82.3%的病例中,已确定的CyKD基因中确定了可能引起疾病的罕见变异.
- 在COL4A3和PKHD1.1中发现了重要的基因信号.
- 对一些最近与自身主导性多囊性病相关的基因,量化显著降低遗传风险.
- 常见变异对欧洲祖先的CKD遗传性贡献最小 (3% - 9%).
结论:
- 对基因特异性风险影响的不偏见量化表明,并非所有罕见变异都表现为CyKD中的经典门德尔特征.
- 这项研究为CKD临床环境中的基因测试和咨询提供了宝贵的见解.
- 突出了囊性病的复杂遗传景观,超出了简单的门德尔遗传模式.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.7K
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
12.9K
相关概念视频
02:26Comparing Copy Number Variations and SNPs
17.7K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.7K
01:11Genome-wide Association Studies-GWAS
13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.2K